193 related articles for article (PubMed ID: 9842890)
1. Maternal-fetal tolerance is maintained despite transgene-driven trophoblast expression of MHC class I, and defects in Fas and its ligand.
Rogers AM; Boime I; Connolly J; Cook JR; Russell JH
Eur J Immunol; 1998 Nov; 28(11):3479-87. PubMed ID: 9842890
[TBL] [Abstract][Full Text] [Related]
2. The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces.
Guller S; LaChapelle L
Semin Reprod Endocrinol; 1999; 17(1):39-44. PubMed ID: 10406074
[TBL] [Abstract][Full Text] [Related]
3. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus.
Kauma SW; Huff TF; Hayes N; Nilkaeo A
J Clin Endocrinol Metab; 1999 Jun; 84(6):2188-94. PubMed ID: 10372730
[TBL] [Abstract][Full Text] [Related]
4. Fetal expression of Fas ligand is necessary and sufficient for induction of CD8 T cell tolerance to the fetal antigen H-Y during pregnancy.
Vacchio MS; Hodes RJ
J Immunol; 2005 Apr; 174(8):4657-61. PubMed ID: 15814689
[TBL] [Abstract][Full Text] [Related]
5. Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion.
Uckan D; Steele A; Cherry ; Wang BY; Chamizo W; Koutsonikolis A; Gilbert-Barness E; Good RA
Mol Hum Reprod; 1997 Aug; 3(8):655-62. PubMed ID: 9294848
[TBL] [Abstract][Full Text] [Related]
6. Why is the fetal allograft not rejected?
Davies CJ
J Anim Sci; 2007 Mar; 85(13 Suppl):E32-5. PubMed ID: 17040952
[TBL] [Abstract][Full Text] [Related]
7. Fas and Fas-ligand are expressed in the uteroplacental unit of first-trimester pregnancy.
Hammer A; Blaschitz A; Daxböck C; Walcher W; Dohr G
Am J Reprod Immunol; 1999 Jan; 41(1):41-51. PubMed ID: 10097786
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level.
Frängsmyr L; Baranov V; Nagaeva O; Stendahl U; Kjellberg L; Mincheva-Nilsson L
Mol Hum Reprod; 2005 Jan; 11(1):35-41. PubMed ID: 15579659
[TBL] [Abstract][Full Text] [Related]
9. Expression of allogeneic MHC class I antigens by transgenic mouse trophoblast does not interfere with the normal course of pregnancy.
Shomer B; Toder V; Egorov I; Ehrlich R
Transgenic Res; 1998 Sep; 7(5):343-55. PubMed ID: 9859223
[TBL] [Abstract][Full Text] [Related]
10. Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease.
Mor G; Gutierrez LS; Eliza M; Kahyaoglu F; Arici A
Am J Reprod Immunol; 1998 Aug; 40(2):89-94. PubMed ID: 9764350
[TBL] [Abstract][Full Text] [Related]
11. FAS/FAS ligand interaction at the placental interface is not required for the success of allogeneic pregnancy in anti-paternal MHC preimmunized mice.
Chaouat G; Clark DA
Am J Reprod Immunol; 2001 Feb; 45(2):108-15. PubMed ID: 11216873
[TBL] [Abstract][Full Text] [Related]
12. Species diversity in the immunogenetic relationship between mother and fetus: is trophoblast insusceptibility to immunological destruction the only essential common feature for the maintenance of allogeneic pregnancy?
Billington WD
Exp Clin Immunogenet; 1993; 10(2):73-84. PubMed ID: 8251182
[TBL] [Abstract][Full Text] [Related]
13. HLA Class I protein expression in the human placenta.
Blaschitz A; Hutter H; Dohr G
Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
[TBL] [Abstract][Full Text] [Related]
14. Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege.
Ohshima K; Nakashima M; Sonoda K; Kikuchi M; Watanabe T
Clin Exp Immunol; 2001 Mar; 123(3):481-6. PubMed ID: 11298137
[TBL] [Abstract][Full Text] [Related]
15. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus.
Hunt JS; Vassmer D; Ferguson TA; Miller L
J Immunol; 1997 May; 158(9):4122-8. PubMed ID: 9126971
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility antigen expression on the bovine placenta: its relationship to abnormal pregnancies and retained placenta.
Davies CJ; Hill JR; Edwards JL; Schrick FN; Fisher PJ; Eldridge JA; Schlafer DH
Anim Reprod Sci; 2004 Jul; 82-83():267-80. PubMed ID: 15271459
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis in the first trimester human placenta: the role in maintaining immune privilege at the maternal-foetal interface and in the trophoblast remodelling.
Jerzak M; Bischof P
Eur J Obstet Gynecol Reprod Biol; 2002 Jan; 100(2):138-42. PubMed ID: 11750952
[TBL] [Abstract][Full Text] [Related]
18. Transgenic major histocompatibility complex class I antigen expressed in mouse trophoblast affects maternal immature B cells.
Aït-Azzouzene D; Caucheteux S; Tchang F; Wantyghem J; Moutier R; Langkopf A; Gendron MC; Kanellopoulos-Langevin C
Biol Reprod; 2001 Aug; 65(2):337-44. PubMed ID: 11466198
[TBL] [Abstract][Full Text] [Related]
19. Trophoblast debris modulates the expression of immune proteins in macrophages: a key to maternal tolerance of the fetal allograft?
Abumaree MH; Chamley LW; Badri M; El-Muzaini MF
J Reprod Immunol; 2012 Jun; 94(2):131-41. PubMed ID: 22542910
[TBL] [Abstract][Full Text] [Related]
20. Allo-antigenicity of trophoblast cells.
Chatterjee-Hasrouni S; Montgomery B; Lala PK
Am J Reprod Immunol (1980); 1983; 3(3):127-31. PubMed ID: 6191582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
